Pawan Parakh highlights pharma’s revenue growth from pipelines, multi-year potential in defence, and telecom gains from tariff hikes and 5G shifts. Airtel’s Rs 300 ARPU target is crucial. Renewables and automation see margin improvement via operating leverage. Defence export commitments to Southeast Asia highlight India’s atmanirbhar focus, with Sunil Mittal underscoring enterprise telecom.
| Subscribe To Our Free Newsletter |
